A Trial on the Efficacy, Safety and Immunogenicity of Live-Attenuated Influenza Vaccine (LAIV)
Clinical trial NCT02964065 · COMPLETED
Trial details
- NCT number
- NCT02964065
- Sponsor
- Changchun BCHT Biotechnology Co.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-01
- Primary completion
- 2017-08-01
- Enrollment
- 9000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.